{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:09:10Z","timestamp":1786997350281,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.taap.2025.117619","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:58:01Z","timestamp":1761591481000},"page":"117619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Magnolol targets CCND1 to suppress the proliferation of cholangiocarcinoma cells by inhibiting the Akt and STAT3 pathways"],"prefix":"10.1016","volume":"506","author":[{"given":"Wenhui","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghui","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"30","key":"10.1016\/j.taap.2025.117619_bb0005","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.2174\/0115680266261150231110053650","article-title":"To investigate growth factor receptor targets and generate Cancer targeting inhibitors","volume":"23","author":"Basu","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"issue":"19","key":"10.1016\/j.taap.2025.117619_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197034","article-title":"Redox regulation of STAT1 and STAT3 signaling","volume":"21","author":"Butturini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.taap.2025.117619_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2023.102676","article-title":"Amorphous solid dispersion preparation via coprecipitation improves the dissolution, oral bioavailability, and intestinal health enhancement properties of magnolol","volume":"102","author":"Cao","year":"2023","journal-title":"Poult. Sci."},{"issue":"7","key":"10.1016\/j.taap.2025.117619_bb0020","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.21037\/jtd.2019.07.46","article-title":"Magnolol inhibits growth and induces apoptosis in esophagus cancer KYSE-150 cell lines via the MAP kinase pathway","volume":"11","author":"Chen","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.taap.2025.117619_bb0025","first-page":"94","article-title":"Magnolol and 5-fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K\/AKT\/mTOR and EMT pathways","volume":"16","author":"Chen","year":"2024","journal-title":"Chin Herb Med"},{"key":"10.1016\/j.taap.2025.117619_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155946","article-title":"Paeoniflorin inhibits PRAS40 interaction with raptor to activate mTORC1 to reverse excessive autophagy in airway epithelial cells for asthma","volume":"134","author":"Cheng","year":"2024","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.taap.2025.117619_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16122257","article-title":"The anticancer application of delivery Systems for Honokiol and Magnolol","volume":"16","author":"Dominiak","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.taap.2025.117619_bb0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1186\/s12885-019-5793-z","article-title":"CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT\/CCND1 pathway in vitro and in vivo","volume":"19","author":"Feng","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.taap.2025.117619_bb0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.taap.2025.117619_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102170","article-title":"Targeting FGFR inhibition in cholangiocarcinoma","volume":"95","author":"Goyal","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.taap.2025.117619_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/03000605241234006","article-title":"The potential mechanism of ursolic acid in the treatment of bladder cancer based on network pharmacology and molecular docking","volume":"52","author":"Huang","year":"2024","journal-title":"J. Int. Med. Res."},{"issue":"11","key":"10.1016\/j.taap.2025.117619_bb0060","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1007\/s11033-022-07788-1","article-title":"The cell cycle, cancer development and therapy","volume":"49","author":"Jamasbi","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.taap.2025.117619_bb0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.suc.2018.12.004","article-title":"Cholangiocarcinoma","volume":"99","author":"Khan","year":"2019","journal-title":"Surg. Clin. North Am."},{"issue":"2","key":"10.1016\/j.taap.2025.117619_bb0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.31557\/APJCP.2023.24.2.575","article-title":"Predictive factors for post-hepatectomy liver failure in patients with cholangiocarcinoma","volume":"24","author":"Kriengkrai","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.taap.2025.117619_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/jcar.JCar_17_18","article-title":"Molecular pathways of oral cancer that predict prognosis and survival: a systematic review","volume":"17","author":"Lakshminarayana","year":"2018","journal-title":"J Carcinog"},{"issue":"10","key":"10.1016\/j.taap.2025.117619_bb0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/cas.12762","article-title":"Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway","volume":"106","author":"Li","year":"2015","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.taap.2025.117619_bb0085","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.21873\/anticanres.17262","article-title":"Magnolol induces apoptosis and suppresses immune evasion in non-small cell lung Cancer xenograft models","volume":"44","author":"Lin","year":"2024","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.taap.2025.117619_bb0090","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11912-024-01540-7","article-title":"CDK4\/6 inhibitors: the devil is in the detail","volume":"26","author":"Magge","year":"2024","journal-title":"Curr. Oncol. Rep."},{"issue":"7","key":"10.1016\/j.taap.2025.117619_bb0095","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/01635581.2014.951736","article-title":"Magnolol causes alterations in the cell cycle in androgen insensitive human prostate cancer cells in vitro by affecting expression of key cell cycle regulatory proteins","volume":"66","author":"McKeown","year":"2014","journal-title":"Nutr. Cancer"},{"issue":"12","key":"10.1016\/j.taap.2025.117619_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in Cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma","volume":"9","author":"Montalto","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.taap.2025.117619_bb0105","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/01635581.2021.1931364","article-title":"Natural Lignans Honokiol and Magnolol as potential Anticarcinogenic and anticancer agents. A Comprehensive Mechanistic Review","volume":"74","author":"Mottaghi","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.taap.2025.117619_bb0110","doi-asserted-by":"crossref","unstructured":"Naponelli V, Rocchetti MT and Mangieri D. Apigenin: Molecular mechanisms and therapeutic potential against Cancer spreading. Int. J. Mol. Sci., 2024. 25(10).","DOI":"10.3390\/ijms25105569"},{"issue":"12","key":"10.1016\/j.taap.2025.117619_bb0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","article-title":"Cyclin D1, cancer progression, and opportunities in cancer treatment","volume":"94","author":"Qie","year":"2016","journal-title":"J. Mol. Med. (Berl)"},{"issue":"8","key":"10.1016\/j.taap.2025.117619_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082362","article-title":"Magnolol: a Neolignan from the Magnolia family for the prevention and treatment of Cancer","volume":"19","author":"Ranaware","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.taap.2025.117619_bb0125","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/hep.30704","article-title":"Dependency of cholangiocarcinoma on cyclin D-dependent kinase activity","volume":"70","author":"Sittithumcharee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2025.117619_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.877194","article-title":"The acquired vulnerability caused by CDK4\/6 inhibition promotes drug synergism between Oxaliplatin and Palbociclib in cholangiocarcinoma","volume":"12","author":"Suppramote","year":"2022","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.taap.2025.117619_bb0135","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.apsb.2021.06.007","article-title":"Synergistic effects of autophagy\/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy","volume":"11","author":"Tang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.taap.2025.117619_bb0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/14740338.2023.2227561","article-title":"A drug safety evaluation of pemigatinib for advanced cholangiocarcinoma","volume":"22","author":"Uson","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.taap.2025.117619_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-2736-5_1","article-title":"Cell cycle progression and synchronization: an overview","volume":"2579","author":"Wang","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"19","key":"10.1016\/j.taap.2025.117619_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196441","article-title":"Magnolol as a potential anticancer agent: a proposed mechanistic insight","volume":"27","author":"Wang","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.taap.2025.117619_bb0155","first-page":"5902","article-title":"Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer","volume":"7","author":"Zhang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.taap.2025.117619_bb0160","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biopha.2017.07.085","article-title":"Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-\u03baB signaling pathway","volume":"94","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"19","key":"10.1016\/j.taap.2025.117619_bb0165","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1002\/jssc.202100982","article-title":"Pharmacokinetics and metabolites of glycosides and lignans of the stem bark of Magnolia officinalis in functional dyspepsia and normal rats using liquid chromatography-tandem mass spectrometry","volume":"45","author":"Zhang","year":"2022","journal-title":"J. Sep. Sci."},{"issue":"4","key":"10.1016\/j.taap.2025.117619_bb0170","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/HEP.0000000000000552","article-title":"PTPN9 dephosphorylates FGFR2 pY656\/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma","volume":"79","author":"Zhao","year":"2024","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.taap.2025.117619_bb0175","doi-asserted-by":"crossref","first-page":"17067","DOI":"10.1002\/jcb.28968","article-title":"Magnolol induces apoptosis in osteosarcoma cells via G0\/G1 phase arrest and p53-mediated mitochondrial pathway","volume":"120","author":"Zhou","year":"2019","journal-title":"J. Cell. Biochem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25003953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:51:33Z","timestamp":1780908693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25003953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"alternative-id":["S0041008X25003953"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117619","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnolol targets CCND1 to suppress the proliferation of cholangiocarcinoma cells by inhibiting the Akt and STAT3 pathways","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117619"}}